Literature DB >> 21052763

Serum ferritin correlates with activity of anti-MDA5 antibody-associated acute interstitial lung disease as a complication of dermatomyositis.

Takahisa Gono1, Yasushi Kawaguchi, Eri Ozeki, Yuko Ota, Takashi Satoh, Masataka Kuwana, Masako Hara, Hisashi Yamanaka.   

Abstract

Dermatomyositis (DM) is occasionally complicated by interstitial lung disease. Acute/subacute interstitial pneumonia (A/SIP) with DM is intractable and life threatening. Clinically amyopathic dermatomyositis (C-ADM) is also reported to be complicated with A/SIP, especially in those patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody. In the present cases, we indicate that serum ferritin level correlated with activity of A/SIP with DM. Two patients, a 65-year-old woman and a 30-year-old woman, were diagnosed with anti-MDA5 antibody-associated A/SIP with DM. Serum ferritin was high, 1600 and 770 mg/dl, respectively, on admission. Immunosuppressive therapy ameliorated A/SIP in both cases. Similarly, serum ferritin was also decreasing. However, A/SIP was recurrent and progressive, and serum ferritin was also increasing again in one case. In conclusion, serum ferritin correlates with disease activity of anti-MDA5 antibody-associated A/SIP with DM. Intensity of treatment may be decided according to serum ferritin level.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21052763     DOI: 10.1007/s10165-010-0371-x

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  18 in total

1.  Serum YKL-40 level is associated with severity of interstitial lung disease and poor prognosis in dermatomyositis with anti-MDA5 antibody.

Authors:  Lili Jiang; Youlian Wang; Qinglin Peng; Xiaoming Shu; Guochun Wang; Xiaomu Wu
Journal:  Clin Rheumatol       Date:  2019-02-09       Impact factor: 2.980

Review 2.  Interstitial lung disease in myositis: clinical subsets, biomarkers, and treatment.

Authors:  Tsuneyo Mimori; Ran Nakashima; Yuji Hosono
Journal:  Curr Rheumatol Rep       Date:  2012-06       Impact factor: 4.592

Review 3.  A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy.

Authors:  Minoru Satoh; Shin Tanaka; Angela Ceribelli; S John Calise; Edward K L Chan
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

4.  Can serum ferritin level predict disease severity in patients with crimean-congo hemorrhagic Fever?

Authors:  Maliheh Metanat; Batool Sharifi-Mood; Mehdi Tabatabaei; Mohammad Sarraf-Shirazi
Journal:  Eurasian J Med       Date:  2013-06

5.  A New Predictive Model for the Prognosis of MDA5+ DM-ILD.

Authors:  Qian Niu; Li-Qin Zhao; Wan-Li Ma; Liang Xiong; Xiao-Rong Wang; Xin-Liang He; Fan Yu
Journal:  Front Med (Lausanne)       Date:  2022-06-15

6.  Anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis complicated with macrophage activation syndrome.

Authors:  Yukang Ding; Yongpeng Ge
Journal:  Ther Adv Chronic Dis       Date:  2022-05-13       Impact factor: 4.970

7.  Predictive factors of rapidly progressive-interstitial lung disease in patients with clinically amyopathic dermatomyositis.

Authors:  Y Xu; C S Yang; Y J Li; X D Liu; J N Wang; Q Zhao; W G Xiao; P T Yang
Journal:  Clin Rheumatol       Date:  2015-12-10       Impact factor: 2.980

8.  Serum progranulin levels are elevated in dermatomyositis patients with acute interstitial lung disease, predicting prognosis.

Authors:  Atsushi Tanaka; Hiroshi Tsukamoto; Hiroki Mitoma; Chikako Kiyohara; Naoyasu Ueda; Masahiro Ayano; Shun-ichiro Ohta; Yasutaka Kimoto; Mitsuteru Akahoshi; Yojiro Arinobu; Hiroaki Niiro; Yoshifumi Tada; Takahiko Horiuchi; Koichi Akashi
Journal:  Arthritis Res Ther       Date:  2015-02-10       Impact factor: 5.156

9.  Chemokine profiles of interstitial pneumonia in patients with dermatomyositis: a case control study.

Authors:  Katsuhiro Oda; Takuya Kotani; Tohru Takeuchi; Takaaki Ishida; Takeshi Shoda; Kentaro Isoda; Shuzo Yoshida; Yasuichiro Nishimura; Shigeki Makino
Journal:  Sci Rep       Date:  2017-05-09       Impact factor: 4.379

10.  A Case of Polymyxin b-Immobilized Fiber Column Treatment for Rapidly Progressive Interstitial Pneumonia Associated with Clinically Amyopathic Dermatomyositis.

Authors:  Oh Sasaki; Makoto Dohi; Hiroaki Harada; Mitsuru Imamura; Yumi Tsuchida; Kensuke Yamaguchi; Toshihiko Komai; Kazuhiko Yamamoto
Journal:  Case Rep Med       Date:  2013-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.